Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2009 - 2026)

Johnson & Johnson has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $201.1 billion for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 3.97% year-over-year to $201.1 billion; the TTM figure through Jun 2026 stood at $794.0 billion (up 6.51% YoY), while the FY2025 annual figure was $199.2 billion, up 10.61% from the prior year.
• Liabilities and Shareholders Equity came in at $201.1 billion for Q2 2026 at Johnson & Johnson, roughly flat from $200.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $201.1 billion in Q2 2026 to a low of $166.1 billion in Q4 2023.
• Average Liabilities and Shareholders Equity over 5 years is $185.0 billion, with a median of $182.0 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity decreased 12.25% in 2024 and advanced 12.62% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $175.1 billion in 2022, then retreated by 4.32% to $167.6 billion in 2023, then gained by 7.49% to $180.1 billion in 2024, then gained by 10.61% to $199.2 billion in 2025, then increased by 0.93% to $201.1 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $201.1 billion in Q2 2026, $200.9 billion in Q1 2026, and $199.2 billion in Q4 2025.